New treatment for spinocerebellar degeneration (SCD)
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests an experimental drug, KPS-0373, to see if it can help people with spinocerebellar degeneration (a condition that affects coordination and balance). It is for Japanese patients with mild to moderate trouble with movement (ataxia).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with spinocerebellar degeneration (SCD).
- You must have mild to moderate problems with coordination and balance (ataxia).
- You must be living in Japan.
- Your ataxia must not be caused by another condition (secondary ataxia).
- You should not have serious liver, kidney, or heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive brain stimulation method called transcranial temporal interference stimulation to see if it can improve symptoms of spinocerebellar ataxia type 3 (a condition affecting balance and coordination). It aims to find the best stimulation settings to help with movement and gait.
This trial tests whether deep brain stimulation (DBS) can improve walking and coordination in people with SCA1 or SCA3, two genetic conditions that cause ataxia. If you are an adult with moderate ataxia, this might be a new option to explore.
This study tests a noninvasive electrical stimulation therapy applied to the spine to see if it can improve movement and coordination in people with spinocerebellar ataxia. It may help with walking and balance.
This trial studies whether riluzole can help people with spinocerebellar ataxia type 7 (SCA7), a genetic condition that affects balance and coordination. It may help slow symptoms or improve daily function, and you’d be closely monitored for side effects.
This trial tests a stem cell therapy called Stemchymal® for people with a specific type of hereditary ataxia (SCA3). It aims to see if the treatment can improve balance and coordination.
This Phase 2 study tests an umbilical cord “stem cell” treatment to improve symptoms in people with spinocerebellar ataxia (a nerve condition that affects balance and walking). It may help walking ability and overall ataxia symptoms, but you must meet specific health and lab safety checks.
Hear when a new Spinocerebellar Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.